News & Updates
Event Calendar
June 17, 2013 - 4:00pm
June 22, 2013 (All day)
Search Research Content
Resource Finder at Kennedy Krieger Institute
A free resource that provides access to information and support for individuals and families living with developmental disabilities.
Bromocriptine reduces steatosis in obese rodent models.
| Title | Bromocriptine reduces steatosis in obese rodent models. |
| Publication Type | Journal Article |
| Year of Publication | 2006 |
| Authors | Davis LM, Pei Z, Trush MA, Cheskin LJ, Contoreggi C, McCullough K, Watkins PA, Moran TH |
| Journal | Journal of hepatology |
| Volume | 45 |
| Issue | 3 |
| Pagination | 439-44 |
| Date Published | 2006 Sep |
| Abstract | Obesity is a risk factor for glucose intolerance, steatosis, and oxidative stress, characteristics of nonalcoholic fatty liver disease. Bromocriptine may have anti-obesity, insulin-sensitizing, lipolytic, and antioxidant properties. We, therefore, hypothesized that bromocriptine would improve markers of nonalcoholic fatty liver disease in obese rodent models. |
| Alternate Journal | J. Hepatol. |
Your Support is the Key
Help children like Matthew unlock their potential by becoming a Partner in Potential.
